Are Medical Stocks Lagging Arcutis Biotherapeutics (ARQT) This Year?

For Tenet Healthcare, the consensus EPS estimate for the current year has increased 24.5% over the past three months. The stock currently has a Zacks Rank #1 (Strong Buy). Looking more specifically, Arcutis Biotherapeutics, Inc. belongs to the Medical - Biomedical and Genetics industry, a group that includes 489 individual stocks and currently sits at #147 in the Zacks Industry Rank. Stocks in this group have lost about 0.4% so far this year, so ARQT is performing better this group in terms of year-to-date ...